cinobufotalin has been researched along with Liver Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Itokawa, H; Kamano, Y; Katsuyama, M; Morita, H; Nogawa, T; Pettit, GR; Saito, K; Segawa, T; Takeya, K; Yamashita, A; Yukita, A | 1 |
| Dou, Y; Fang, D; Li, W; Pei, S; Qi, D; Sun, H; Xie, S; Yang, R; Yao, X; Zhang, W; Zhang, X; Zhang, Z | 1 |
| Fang, W; Han, S; Hou, R; Huang, Y; Li, A; Li, Y; Liu, C; Liu, J; Liu, S; Liu, Z; Luo, X; Yang, H; Zhang, W; Zhang, Y | 1 |
| Wang, LS; Wang, PP; Wang, YH; Wu, T | 1 |
| Huang, G; Li, J; Li, X; Liu, J; Meng, H; Shen, M; Zhang, R; Zhao, L | 1 |
| Bai, XM; Chen, YZ; Cheng, L; Gu, XS; Jin, Y; Peng, Y; Yi, N | 1 |
| Fu, XX; Liu, Z; Zhang, NL | 1 |
7 other study(ies) available for cinobufotalin and Liver Neoplasms
| Article | Year |
|---|---|
QSAR evaluation of the Ch'an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5(1).
Topics: Antineoplastic Agents; Bufanolides; Colchicine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms; Models, Molecular; Quantitative Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |
Cinobufotalin inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells through down-regulate β-catenin in vitro and in vivo.
Topics: beta Catenin; Bufanolides; Cadherins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms | 2022 |
ENKUR expression induced by chemically synthesized cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating β-catenin/c-Jun/MYH9/USP7/c-Myc axis.
Topics: Adaptor Proteins, Signal Transducing; beta Catenin; Bufanolides; Calmodulin-Binding Proteins; Carcinoma, Hepatocellular; Catenins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Myosin Heavy Chains; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-myc; Ubiquitin-Specific Peptidase 7 | 2022 |
[Anti-tumor effect and its related mechanisms of cinobufotalin combined with cisplatin on H22 liver cancer mice].
Topics: Animals; Apoptosis; Bufanolides; Carcinoma, Hepatocellular; Cisplatin; Fas Ligand Protein; Liver Neoplasms; Mice | 2020 |
Novel SREBP1 inhibitor cinobufotalin suppresses proliferation of hepatocellular carcinoma by targeting lipogenesis.
Topics: Animals; Apoptosis; Bufanolides; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Lipogenesis; Liver Neoplasms; Male; Mice; Molecular Docking Simulation; Sterol Regulatory Element Binding Protein 1; Xenograft Model Antitumor Assays | 2021 |
Ceramide production mediates cinobufotalin-induced growth inhibition and apoptosis in cultured hepatocellular carcinoma cells.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Bufanolides; Carcinoma, Hepatocellular; Cell Proliferation; Ceramides; Gene Expression Regulation, Neoplastic; Glucosyltransferases; Hep G2 Cells; Humans; Liver Neoplasms; Morpholines; Sphingosine N-Acyltransferase | 2015 |
[Inhibitory effects of co-cinobufotalin oral liquor on hepatitis B in vitro].
Topics: Antiviral Agents; Bufanolides; Carcinoma, Hepatocellular; DNA Replication; Hepatitis B virus; Humans; Liver Neoplasms; Materia Medica; Transfection; Tumor Cells, Cultured; Virus Replication | 1996 |